CNXU · Conexeu Sciences Inc. · Exempt Offerings
$2.18
-0.08 (-3.54%)
At close · Nov 12
Return incl. dividend (before tax)
Going-concern doubt
— flagged Sep 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt about the Company's ability to continue as a going concern within one year after the date of these unaudited condensed interim financial statements being issued. The ability of the Company to continue as a going concern is dependent upon the Company's ability to raise additional funds and implement its business plan. These unaudited condensed interim financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern. Such adjustments could be material.”View the 10-Q filed Sep 14, 2026
Market Cap
$61.49M
Shares
28.21M
Volume · Nov 12
149.98K
Avg daily vol (3M)
289.05K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.
| Filed | Type | Industry | Offering | Sold | Exemptions |
|---|---|---|---|---|---|
| 2026-11-05 | New | Biotechnology | $4,801 | $4,801 | 06b |
| 2026-11-05 | New | Biotechnology | $21,645 | $21,645 | 06b |
| 2026-10-21 | New | Biotechnology | $2,999,994 | $1,499,997 | 06b |
| 2026-09-29 | New | Biotechnology | $30,875 | $30,875 | 06b |
| 2026-09-15 | New | Biotechnology | $252,148 | $252,148 | 06b |
| 2026-08-31 | New | Biotechnology | $88,548 | $88,548 | 06b |
| 2026-07-31 | New | Biotechnology | $62,725 | $62,725 | 06b |
| 2026-06-30 | New | Biotechnology | $86,320 | $86,320 | 06b |
| 2026-06-30 | New | Biotechnology | $465,953 | $203 | 06b |
| 2026-06-12 | Amendment | Biotechnology | $2,200 | $1,700 | 06b |
| 2026-06-10 | New | Biotechnology | $137,427 | $22,905 | 06b |
| 2026-05-21 | New | Biotechnology | $44,700 | $44,700 | 06b |
| 2026-05-21 | New | Biotechnology | $1,248,634 | $543 | 06b |
| 2026-04-01 | New | Biotechnology | $1,815,000 | $1,815,000 | 06b |
| 2026-03-23 | New | Biotechnology | $44,698 | $44,698 | 06b |
| 2026-02-27 | New | Biotechnology | $1,072,437 | $467 | 06b |
| 2026-02-04 | New | Biotechnology | $810,000 | $810,000 | 06b |
| 2025-11-20 | New | Biotechnology | $202,299 | $202,299 | 06b |
| 2025-11-13 | New | Biotechnology | $2,921,446 | $2,921,446 | 06b |
| 2025-07-02 | Amendment | Biotechnology | $2,531,964 | $1,287,329 | 06b |
| 2025-06-13 | New | Biotechnology | $2,200 | $1,200 | 06b |
| 2025-05-09 | New | Biotechnology | $2,411,964 | $1,287,329 | 06b |
Showing 1–22 of 22 filings
Key facts
CIK
2066836
CUSIP
20715F100
13F (30d)
15 filings
15 filers
Visit website
Investor relations